http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535084-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1087 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 |
| filingDate | 2008-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010535084-A |
| titleOfInvention | System and method for delivering enhanced treatment with particle radiation |
| abstract | Systems and methods that enhance selective targeting of agent 204 to prioritize effects at the target while reducing effects at healthy tissue distal to the target tissue. One or more agents 204 may be combined with the nanoscale structures / particles 202 for delivery to the target tissue. Appropriate bombardment with accelerated particle radiation, such as proton radiation, triggers the release of agent 204 at the target site. Nanocarriers can be combined with therapeutic agents and / or imaging enhancers 204. Target tissue imaging may provide verification of the dose of delivered particle radiation. Nanocarriers are selected for biocompatibility and durability in the body environment, accelerate the release of agent 204 by providing a feedback mechanism in the processing environment, and the total radiation required for the release. An outer shell may be provided that is further selected to reduce the dose. [Selection] Figure 1 |
| priorityDate | 2007-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.